Zobrazeno 1 - 10
of 19
pro vyhledávání: '"I. M. Hamour"'
Autor:
David H. Mortsell, Nicholas R. Banner, Direndra Rajaruthnam, Wajid Hussain, Vias Markides, Tom Wong, David G. Jones, I. M. Hamour
Publikováno v:
The Journal of Heart and Lung Transplantation. 30:1257-1265
Background Permanent pacemaker implantation (PPM) early after cardiac transplantation has been shown not to predict a worse outcome. However, the requirement for pacing late after transplantation and its prognostic implications are not fully known. W
Autor:
John D. Smith, Marlene L. Rose, I. M. Hamour, Miyuki Ozawa, A. Goh, Paul I. Terasaki, Derek R. Robinson, Nicholas R. Banner
Publikováno v:
American Journal of Transplantation. 11:312-319
Preformed donor HLA-specific antibodies are a known indicator for poor patient survival after cardiac transplantation. The role of de novo donor-specific antibodies (DSA) formed after cardiac transplantation is less clear. Here we have retrospectivel
Publikováno v:
American Journal of Transplantation. 7:2809-2815
The standard method to detect pretransplant antibodies has been the complement dependent cytotoxicity (CDC) test of donor leukocytes. Solid phase assays to detect HLA antibodies in pretransplant serum reveal a greater number of sensitized patients, b
Publikováno v:
Transplantation. 83:570-576
BACKGROUND Mycophenolate mofetil (MMF) provides superior prophylaxis against acute rejection when compared with azathioprine (AZA) in heart and renal transplantation. However, it remains unclear whether this results in improved survival or reduced mo
Publikováno v:
QJM : monthly journal of the Association of Physicians. 104(4)
Background : Heart transplantation (HTx), the gold standard therapy for advanced heart failure, is limited by donor availability; alternative therapies are now becoming available. Aim: We examined the outcome of HTx with current immunosuppressive and
Autor:
I. M. Hamour, Gilles D. Dreyfus, Margaret Burke, Nicholas R. Banner, H. Lyster, Michael J. Boscoe
Publikováno v:
Surgical Intensive Care Medicine ISBN: 9780387778921
Heart transplantation has become established as a highly successful therapy for selected patients with advanced cardiac failure.Long-term survival rates after transplantation far exceed those achieved by medical therapy for this condition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cc35a1f23f7e91add5641fc7855a855
https://doi.org/10.1007/978-0-387-77893-8_51
https://doi.org/10.1007/978-0-387-77893-8_51
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 24(12)
Background. Chronic kidney disease is common after heart transplantation, and is related to ciclosporin (CsA) therapy. We compared the safety and efficacy of two ciclosporin withdrawal regimens. Methods. CsA was stopped and sirolimus (SRL) commenced
Autor:
Marlene L. Rose, N.R. Banner, S. Jigjidsuren, V. M. Brunner, Ann McCormack, I. M. Hamour, John D. Smith
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9(8)
Little is known about the effect of MICA antibodies (Abs) on cardiac allograft function and survival. Pretransplant and posttransplant serum from 491 and 196 adult cardiac allograft recipients, respectively, has been investigated for MICA Abs, donor
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 24(5)
Background. Chronic kidney disease (CKD) is a complication of heart transplantation related to calcineurin inhibitor nephrotoxicity. However, it is unclear whether early ciclosporin (CsA) exposure influences CKD in the long term. Methods. We analysed
Autor:
Mathen G. Panicker, Nicholas R. Banner, Margaret Burke, Rajasi Banerjee, Alex D. Bell, I. M. Hamour
Publikováno v:
Transplantation. 85(7)
BACKGROUND Surveillance endomyocardial biopsies (EMBs) are used for the early diagnosis of acute cardiac allograft rejection. Protocols became standardized in an earlier era and their utility with contemporary immunosuppression has not been investiga